Magazine article Clinical Psychiatry News

Senate Oks Bill Limiting Pseudoephedrine Access

Magazine article Clinical Psychiatry News

Senate Oks Bill Limiting Pseudoephedrine Access

Article excerpt

The Senate has again sent a bill to the House that would require retailers selling pseudoephedrine-containing over-the-counter products to train employees to comply with the Combat Methamphetamine Act.

The Combat Methamphetamine Enhancement Act, S. 256, introduced by Sen. Dianne Feinstein (D-Calif.) and Sen. Chuck Grassley (R-Iowa), passed the Senate in early June.

Products containing the ingredient include antihistamine and decongestant products such as Claritin-D, Sudafed, and Zyrtec-D.

The bill, which the Senate also passed in 2008 and which Sen. Feinstein initially introduced in 2007, would impose restrictions on retailers that fail to meet requirements of the Combat Meth Act enacted in 2006.

It would require that distributors deliver PSE- and ephedrine-containing over-the-counter drugs only to retailers that are self-certified through the Drug Enforcement Administration to sell the products.

The 2006 law requires retail employees who sell products containing PSE or ephedrine to receive training outlined on the DEA's Web site.

As in 2008, the fate of Sen. Feinstein's bill rests with the House, where it was referred to the Energy and Commerce Committee with no hearing date set. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.